TGFB1 Antikörper (AA 279-390)
-
- Target Alle TGFB1 Antikörper anzeigen
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Bindungsspezifität
- AA 279-390
-
Reaktivität
- Ratte
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TGFB1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
- Spezifität
- The antibody is a mouse monoclonal antibody raised against TGFb1. It has been selected for its ability to recognize TGFb1 in immunohistochemical staining and western blotting.
- Aufreinigung
- Protein A + Protein G affinity chromatography
- Immunogen
- Recombinant Transforming Growth Factor Beta 1 (TGFb1) corresdonding to Ala279~Ser390 with N-terminal His Tag
- Klon
- C3
- Isotyp
- IgG2b kappa
- Top Product
- Discover our top product TGFB1 Primärantikörper
-
-
- Applikationshinweise
-
Western blotting: 0.5-2 μg/mL
1:500-2000 Immunohistochemistry: 5-20 μg/mL
1:50-200 Immunocytochemistry: 5-20 μg/mL
1:50-200 Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 24 months
-
- Target
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
- Andere Bezeichnung
- Transforming Growth Factor Beta 1 (TGFB1 Produkte)
- Hintergrund
- TGF-B1, CED, DPD1, LAP, Camurati-Engelmann Disease, Latency-associated peptide
- Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
-